Hugo Loureiro

Predicting Treatment Efficacy in Early Clinical Trial Phases at Roche


Tuesday, October 4, 2022


9:56 pm


We have created a new method based on the ROPRO (oncology prognostic score). Our method analyses the longitudinal response of patient cohorts to medications. We conducted a retrospective analysis, where we recreated clinical trials from a large real-world dataset and from real in-house clinical trials. Using this new method we detected the treatment benefit earlier than with established methodology. This case study is showing great promise as a clinical development decision support tool.

Ready to attend?

Register now! Join your peers.

Register now View agenda

Knowledge is everything!
Sign up for our newsletter to receive:

  • 10% off your ticket!
  • insights, interviews, tips, news, and much more about Machine Learning Week Europe
  • price break reminders